结直肠癌原发灶及配对转移灶中KRAS和BRAF的突变情况。 - Suppr

Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.

作者信息

Artale Salvatore, Sartore-Bianchi Andrea, Veronese Silvio Marco, Gambi Valentina, Sarnataro Carolina Silvia, Gambacorta Marcello, Lauricella Calogero, Siena Salvatore

出版信息

J Clin Oncol. 2008 Sep 1;26(25):4217-9. doi: 10.1200/JCO.2008.18.7286.

DOI:10.1200/JCO.2008.18.7286

PMID:18757341

Abstract

摘要

相似文献

Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.结直肠癌原发灶及配对转移灶中KRAS和BRAF的突变情况。

J Clin Oncol. 2008 Sep 1;26(25):4217-9. doi: 10.1200/JCO.2008.18.7286.

Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.原发结直肠腺癌及其转移灶中 KRAS、BRAF 和 PIK3CA 基因突变的流行率和异质性。

Clin Cancer Res. 2010 Feb 1;16(3):790-9. doi: 10.1158/1078-0432.CCR-09-2446. Epub 2010 Jan 26.

Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.具有BRAF、KRAS突变以及这两个癌基因均为野生型的结直肠癌表现出不同的DNA甲基化模式。

J Clin Oncol. 2004 Nov 15;22(22):4584-94. doi: 10.1200/JCO.2004.02.154.

Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.结直肠癌进展过程中p53、K-ras和BRAF基因的突变分析

J Cell Physiol. 2005 Aug;204(2):484-8. doi: 10.1002/jcp.20310.

Cancer Res. 2002 Nov 15;62(22):6451-5.

Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.Ras信号通路频繁参与息肉样型和平坦型早期结直肠癌。

J Exp Clin Cancer Res. 2006 Jun;25(2):235-42.

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.原发性肺腺癌及相应局部区域淋巴结转移灶中的EGFR/KRAS/BRAF基因突变

Clin Cancer Res. 2009 Jul 15;15(14):4554-60. doi: 10.1158/1078-0432.CCR-09-0089. Epub 2009 Jul 7.

KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression.微卫星稳定型结直肠癌进展过程中的KRAS和BRAF致癌突变

Oncogene. 2007 Jan 4;26(1):158-63. doi: 10.1038/sj.onc.1209758. Epub 2006 Sep 4.

Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.结直肠腺癌内镜活检样本和切除标本中 KRAS 和 BRAF 突变的一致性。

Eur J Cancer. 2012 May;48(7):1108-15. doi: 10.1016/j.ejca.2012.02.054. Epub 2012 Mar 23.

Concordant analysis of KRAS status in primary colon carcinoma and matched metastasis.原发结肠癌与匹配转移灶 KRAS 状态的一致性分析。

Anticancer Res. 2010 Oct;30(10):4229-35.

引用本文的文献

Aquaporin 9 downregulation in KRAS colorectal cancer and associated with increased proliferation and decreased apoptosis in cancer cells.水通道蛋白9在KRAS结直肠癌中表达下调，并与癌细胞增殖增加和凋亡减少相关。

Sci Rep. 2025 Apr 10;15(1):12298. doi: 10.1038/s41598-025-95513-w.

Therapeutic strategies targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer.针对转移性结直肠癌中表皮生长因子受体信号通路的治疗策略。

World J Gastrointest Oncol. 2024 Jun 15;16(6):2362-2379. doi: 10.4251/wjgo.v16.i6.2362.

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.比较regorafenib 与基于 5-氟尿嘧啶的再挑战化疗在转移性结直肠癌三线治疗中的疗效。

BMC Cancer. 2024 Jan 2;24(1):16. doi: 10.1186/s12885-023-11783-5.

Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications.解析结直肠癌的复杂性：异质性、克隆进化及临床意义

Cancers (Basel). 2023 Aug 8;15(16):4020. doi: 10.3390/cancers15164020.

Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies.结直肠癌肝转移：聚焦局部治疗的基因组学与生物标志物

Cancers (Basel). 2023 Mar 9;15(6):1679. doi: 10.3390/cancers15061679.

The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1 line treatment of metastatic colorectal (mCRC) patients with wild-type tumour (wt) - a real- life data report 2013-2018.斯洛文尼亚一线治疗野生型肿瘤转移性结直肠癌（mCRC）患者的 5 年 KRAS、NRAS 和 BRAF 分析结果和日常临床实践中的治疗模式 - 真实数据报告 2013-2018.

Radiol Oncol. 2023 Mar 22;57(1):103-110. doi: 10.2478/raon-2023-0014. eCollection 2023 Mar 1.

Mutational Profiles among Colorectal Cancer Patients in the East Coast of Peninsular Malaysia.马来西亚半岛东海岸结直肠癌患者的突变谱

Diagnostics (Basel). 2023 Feb 21;13(5):822. doi: 10.3390/diagnostics13050822.

The impact of RAS mutation on the treatment strategy of colorectal cancer.RAS 突变对结直肠癌治疗策略的影响。

Med Pharm Rep. 2023 Jan;96(1):5-15. doi: 10.15386/mpr-2408. Epub 2023 Jan 25.

Assessing Oncologists' Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real-World Data.评估肿瘤学家在转移性结直肠癌中使用真实世界数据进行生物标志物检测的情况。

JNCI Cancer Spectr. 2022 Nov 1;6(6). doi: 10.1093/jncics/pkac065.

KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer.KRAS 突变驱动的 SUMOylation 控制细胞外囊泡的传递，从而触发胰腺癌中的淋巴管生成。

J Clin Invest. 2022 Jul 15;132(14). doi: 10.1172/JCI157644.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.

作者信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献